NAC Pharmaceuticals (36E797)

NAC Pharmaceuticals (36E797)

Close: May 20, 2026

The Department of Veterans Affairs National Acquisition Center is seeking a single award contract to supply five strengths of Diltiazem SA 24-hour capsules in 90-count bottles to various federal health agencies. The procurement is an unrestricted solicitation for a one-year base period with four subsequent one-year option periods. Requirements include FDA-approved products with unique offeror-specific NDCs and compliance with DSCSA serialization standards.

NAC Pharmaceuticals (36E797)

Close: May 19, 2026

The Department of Veterans Affairs National Acquisition Center (NAC Pharmaceuticals) issued Solicitation #36E79726R0026 seeking supply of Benazepril Hydrochloride (HCL) tablets in multiple strengths and package sizes for federal healthcare customers. The solicitation describes a firm-fixed-price, single-award procurement with specific quality and regulatory requirements (e.g., FDA approval evidence, cGMP documentation, unique NDC numbers) and business reporting obligations. Offers are due May 19, 2026 at 02:30 PM CDT and the solicitation is active on SAM.gov.

NAC Pharmaceuticals (36E797)

Close: Jun 9, 2026

The Department of Veterans Affairs (VA) National Acquisition Center intends to issue RFP 36E79726R0025 for an unrestricted procurement of Mesalamine 1200 mg enteric-coated delayed-release tablets packaged as unit-of-use 120-tablet bottles to serve VA, DoD, BOP, IHS, and Federal Health Care Centers. The contract will be awarded to a single responsible offeror for a one-year base term with four pre-priced one-year options and requires unique NDC-labeled product and strict packaging specifications. The formal solicitation will be issued in commercial item format on or about May 25, 2026, with a tentative closing date of June 9, 2026.